Cargando…
Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation
BACKGROUND: The 2015 American Thyroid Association guidelines supported active surveillance (AS) as a strategy for managing select low-risk thyroid cancers. Data examining physicians’ attitudes about the acceptability of this option are limited. This study aimed to characterize the barriers and facil...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080390/ https://www.ncbi.nlm.nih.gov/pubmed/33910527 http://dx.doi.org/10.1186/s12885-021-08230-8 |
_version_ | 1783685416091648000 |
---|---|
author | Jensen, Catherine B. Saucke, Megan C. Pitt, Susan C. |
author_facet | Jensen, Catherine B. Saucke, Megan C. Pitt, Susan C. |
author_sort | Jensen, Catherine B. |
collection | PubMed |
description | BACKGROUND: The 2015 American Thyroid Association guidelines supported active surveillance (AS) as a strategy for managing select low-risk thyroid cancers. Data examining physicians’ attitudes about the acceptability of this option are limited. This study aimed to characterize the barriers and facilitators to implementing AS as perceived by practicing endocrinologists and surgeons in the United States. METHODS: We conducted 24 semi-structured interviews probing physicians’ attitudes toward AS for patients with small, low-risk thyroid cancer. We used deductive content analysis guided by a well-known model of guideline implementation. Analysis characterized concepts and themes related to AS implementation as physician, guideline, or external factors. We performed member checking to validate results. RESULTS: The most prominent barriers to AS were related to physician factors, although guideline-specific and external barriers were also observed. Physician attitudes towards AS comprised the majority of physician-related barriers, while lack of knowledge about the guideline was also discussed. Participants’ concerns about the potential negative outcomes resulting from observing a cancer were notable as were the lack of confidence in performing and offering surveillance. Beliefs about patient expectations and lack of knowledge about the guideline were also identified as barriers to offering surveillance. Guideline-specific and external barriers included the vagueness of surveillance protocols, lack of data supporting active surveillance, and societal beliefs about cancer. Facilitators of active surveillance included patients’ desire to avoid surgery and shared decision-making. CONCLUSIONS: Barriers and facilitators of active surveillance for low-risk thyroid cancers exist at multiple levels. Strategies to increase adoption of active surveillance should focus on physicians’ attitudes, patient expectations, data supporting surveillance outcomes, and promoting societal-level acceptance of surveillance. |
format | Online Article Text |
id | pubmed-8080390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80803902021-04-29 Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation Jensen, Catherine B. Saucke, Megan C. Pitt, Susan C. BMC Cancer Research BACKGROUND: The 2015 American Thyroid Association guidelines supported active surveillance (AS) as a strategy for managing select low-risk thyroid cancers. Data examining physicians’ attitudes about the acceptability of this option are limited. This study aimed to characterize the barriers and facilitators to implementing AS as perceived by practicing endocrinologists and surgeons in the United States. METHODS: We conducted 24 semi-structured interviews probing physicians’ attitudes toward AS for patients with small, low-risk thyroid cancer. We used deductive content analysis guided by a well-known model of guideline implementation. Analysis characterized concepts and themes related to AS implementation as physician, guideline, or external factors. We performed member checking to validate results. RESULTS: The most prominent barriers to AS were related to physician factors, although guideline-specific and external barriers were also observed. Physician attitudes towards AS comprised the majority of physician-related barriers, while lack of knowledge about the guideline was also discussed. Participants’ concerns about the potential negative outcomes resulting from observing a cancer were notable as were the lack of confidence in performing and offering surveillance. Beliefs about patient expectations and lack of knowledge about the guideline were also identified as barriers to offering surveillance. Guideline-specific and external barriers included the vagueness of surveillance protocols, lack of data supporting active surveillance, and societal beliefs about cancer. Facilitators of active surveillance included patients’ desire to avoid surgery and shared decision-making. CONCLUSIONS: Barriers and facilitators of active surveillance for low-risk thyroid cancers exist at multiple levels. Strategies to increase adoption of active surveillance should focus on physicians’ attitudes, patient expectations, data supporting surveillance outcomes, and promoting societal-level acceptance of surveillance. BioMed Central 2021-04-28 /pmc/articles/PMC8080390/ /pubmed/33910527 http://dx.doi.org/10.1186/s12885-021-08230-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jensen, Catherine B. Saucke, Megan C. Pitt, Susan C. Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation |
title | Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation |
title_full | Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation |
title_fullStr | Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation |
title_full_unstemmed | Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation |
title_short | Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation |
title_sort | active surveillance for thyroid cancer: a qualitative study of barriers and facilitators to implementation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080390/ https://www.ncbi.nlm.nih.gov/pubmed/33910527 http://dx.doi.org/10.1186/s12885-021-08230-8 |
work_keys_str_mv | AT jensencatherineb activesurveillanceforthyroidcanceraqualitativestudyofbarriersandfacilitatorstoimplementation AT sauckemeganc activesurveillanceforthyroidcanceraqualitativestudyofbarriersandfacilitatorstoimplementation AT pittsusanc activesurveillanceforthyroidcanceraqualitativestudyofbarriersandfacilitatorstoimplementation |